-
NRT's 90Y-NRT6020 Injection Receives Clinical Trial Approval in China
10-19-2026NRT's 90Y-NRT6020 Injection Receives Clinical Trial Approval in ChinaMore -
NRT Phase I/II Clinical Trial Data of Yttrium-90 Carbon Microspheres (NRT6003) was presented at APPLE 2026
07-09-2026NRT Phase I/II Clinical Trial Data of Yttrium-90 Carbon Microspheres (NRT6003) was presented at APPLE 2026More
-
NRT Highlights Advances in Precision Nuclear Medicine and Clinical Progress of TareSphere™ at APSCVIR Annual Meeting 2026
06-18-2026NRT Highlights Advances in Precision Nuclear Medicine and Clinical Progress of TareSphere™ at APSCVIR Annual Meeting 2026More
-
NRT at APSCVIR 2026
06-07-2026NRT at APSCVIR 2026More
-
NRT Announces Phase I Clinical Study Data of Yttrium-90 Carbon Microspheres (NRT6003) Injection at 2026 ASCO Annual Meeting
06-07-2026NRT Announces Phase I Clinical Study Data of Yttrium-90 Carbon Microspheres (NRT6003) Injection at 2026 ASCO Annual MeetingMore
-
NRT Achieves Critical Milestone: Radiation Safety License Clears Way for Full-Scale Production of Important Medical Radioisotopes
12-31-2025NRT Achieves Critical Milestone: Radiation Safety License Clears Way for Full-Scale Production of Important Medical RadioisotopesMore